APAC Fecal Occult Blood Tests Market - Industry Trends and Forecast to 2030

Description

List of Tables

Asia-Pacific fecal occult blood testing market is projected to register a substantial CAGR of 4.4 % in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030.

Market Segmentation

Asia-Pacific Fecal Occult Blood Tests Market, By Test Type (Lateral Flow Immuno-Fob Test Kits, Immuno-FOB Agglutination Test Kits, Immuno-FOB ELISA Test Kits, Guaiac FOB Stool Test, Flushable Reagent Pad or Tissue, and Others), By Application (Colorectal Cancer Screening, Concern for Gastrointestinal Bleeding, Polyps, Diverticulosis, Ulcers, Haemorrhoids, Colitis, Anemia, and Others), By End User (Diagnostic Laboratories, Hospitals, Speciality Clinics, and Others), By Distribution Channel (Direct Sales, Retail Sales, E-Commerce, and Others), Country (China, Japan, India, Australia, South Korea, Singapore, Malaysia, Thailand, Indonesia, the Philippines, and the rest of Asia-Pacific.), Industry Trends and Forecast to 2030.

Some of the major factors contributing to the growth of the Asia-Pacific fecal occult blood testing market are:

Rising cases of colorectal cancer globally

Development of direct-to-consumer laboratory testing

Increasing inclination towards point-of-care diagnostics

Easy availability of fecal occult immunological test devices in online stores

Market Players

Some of the key market players for the Asia-Pacific fecal occult blood testing market are listed below:

Quidel Corporation

Siemens Healthcare GmbH

Biohit Oyj

Accubiotech Co.Ltd.

Accuquik Test Kits

Aidian

Alfa Scientific Designs, Inc.

Apacor Limited

Others

1 INTRODUCTION 75

1.1 OBJECTIVES OF THE STUDY 75
1.2 MARKET DEFINITION 75
1.3 OVERVIEW OF THE ASIA PACIFIC FECAL OCCULT BLOOD TESTS MARKET 75
1.4 CURRENCY AND PRICING 77
1.5 LIMITATIONS 77
1.6 MARKETS COVERED 77

2 MARKET SEGMENTATION 81

2.1 MARKETS COVERED 81
2.2 GEOGRAPHICAL SCOPE 82
2.3 YEARS CONSIDERED FOR THE STUDY 83
2.4 DBMR TRIPOD DATA VALIDATION MODEL 84
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 87
2.6 MULTIVARIATE MODELLING 88
2.7 PRODUCT TYPE SEGMENT LIFELINE CURVE 88
2.8 MARKET APPLICATION COVERAGE GRID 89
2.9 DBMR MARKET POSITION GRID 90
2.10 VENDOR SHARE ANALYSIS 91
2.11 SECONDARY SOURCES 92
2.12 ASSUMPTIONS 92

3 EXECUTIVE SUMMARY 93

4 PREMIUM INSIGHTS 95

4.1 PESTEL ANALYSIS 96
4.2 PORTER'S 5 FORCES 97

5 INDUSTRY INSIGHTS 98

6 REGULATORY FRAMEWORK 100

6.1 REGULATORY SCENARIO BY U.S. FDA 100
6.2 REGULATORY SCENARIO IN U.S. 100
6.3 REGULATORY SCENARIO IN EUROPE 101
6.4 REGULATORY SCENARIO IN CANADA 101
6.5 REGULATORY SCENARIO IN AUSTRALIA 101

7 MARKET OVERVIEW 102

7.1 DRIVERS 104
- 7.1.1 RISING CASES OF COLORECTAL CANCER ASIA PACIFICLY 104
- 7.1.2 DEVELOPMENT OF DIRECT-TO-CONSUMER LABORATORY TESTING 104
- 7.1.3 EASY AVAILABILITY OF FECAL OCCULT IMMUNOLOGICAL TEST DEVICES IN ONLINE STORES 105
- 7.1.4 INCREASING INCLINATION TOWARDS POINT-OF-CARE DIAGNOSTICS 105
7.2 RESTRAINTS 105
- 7.2.1 CHANGE IN CONSUMER PREFERENCE TOWARDS COST-EFFECTIVE ALTERNATIVES 105
- 7.2.2 LOW AWARENESS ABOUT FECAL OCCULT BLOOD TESTS IN UNDEVELOPED COUNTRIES 106
7.3 OPPORTUNITIES 106
- 7.3.1 INCREASE IN SCREENING PROCEDURES 106
- 7.3.2 RISING TECHNICAL ADVANCEMENTS 107
- 7.3.3 STRATEGIC INITIATIVES 107
7.4 CHALLENGES 108
- 7.4.1 LACK OF SKILLED PROFESSIONALS 108
- 7.4.2 LOW EFFICIENCY 108

8 ASIA PACIFIC FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE 109

8.1 OVERVIEW 110
8.2 LATERAL FLOW IMMUNO-FOB TEST KITS 113
8.3 IMMUNO-FOB AGGLUTINATION TEST KITS 113
8.4 IMMUNO-FOB ELISA TEST KITS 114
8.5 GUAIAC FOB STOOL TEST 115
- 8.5.1 KITS 116
  - 8.5.1.1 GUAIAC SLIDES 116
    - 8.5.1.1.1 25 PACKAGE 116
    - 8.5.1.1.2 20 PACKAGE 116
    - 8.5.1.1.3 OTHERS 116
  - 8.5.1.2 ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER 117
    - 8.5.1.2.1 SENSITIVITY IS 50NG/ML 117
    - 8.5.1.2.1.1 25 PACKAGE 117
    - 8.5.1.2.1.2 20 PACKAGE 117
    - 8.5.1.2.1.3 OTHERS 118
    - 8.5.1.2.2 SENSITIVITY IS 75NG/ML 118
    - 8.5.1.2.2.1 25 PACKAGE 118
    - 8.5.1.2.2.2 20 PACKAGE 118
    - 8.5.1.2.2.3 OTHERS 118
    - 8.5.1.2.3 OTHERS 118
  - 8.5.1.3 OTHERS 119
- 8.5.2 REAGENTS 119
  - 8.5.2.1 HYDROGEN PEROXIDE 119
  - 8.5.2.2 OTHERS 119
8.6 FLUSHABLE REAGENT PAD OR TISSUE 119
8.7 OTHERS 120

9 ASIA PACIFIC FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION 121

9.1 OVERVIEW 122
9.2 COLORECTAL CANCER SCREENING 125
- 9.2.1 LATERAL FLOW IMMUNO-FOB TEST KITS 126
- 9.2.2 IMMUNO-FOB AGGLUTINATION TEST KITS 126
- 9.2.3 IMMUNO-FOB ELISA TEST KITS 126
- 9.2.4 GUAIAC FOB STOOL TEST 126
- 9.2.5 FLUSHABLE REAGENT PAD OR TISSUE 126
- 9.2.6 OTHERS 126
9.3 CONCERN FOR GASTROINTESTINAL BLEEDING 126
- 9.3.1 LATERAL FLOW IMMUNO-FOB TEST KITS 127
- 9.3.2 IMMUNO-FOB AGGLUTINATION TEST KITS 127
- 9.3.3 IMMUNO-FOB ELISA TEST KITS 127
- 9.3.4 GUAIAC FOB STOOL TEST 128
- 9.3.5 FLUSHABLE REAGENT PAD OR TISSUE 128
- 9.3.6 OTHERS 128
9.4 POLYPS 128
- 9.4.1 LATERAL FLOW IMMUNO-FOB TEST KITS 129
- 9.4.2 IMMUNO-FOB AGGLUTINATION TEST KITS 129
- 9.4.3 IMMUNO-FOB ELISA TEST KITS 129
- 9.4.4 GUAIAC FOB STOOL TEST 129
- 9.4.5 FLUSHABLE REAGENT PAD OR TISSUE 129
- 9.4.6 OTHERS 129
9.5 DIVERTICULOSIS 130
- 9.5.1 LATERAL FLOW IMMUNO-FOB TEST KITS 131
- 9.5.2 IMMUNO-FOB AGGLUTINATION TEST KITS 131
- 9.5.3 IMMUNO-FOB ELISA TEST KITS 131
- 9.5.4 GUAIAC FOB STOOL TEST 131
- 9.5.5 FLUSHABLE REAGENT PAD OR TISSUE 131
- 9.5.6 OTHERS 131
9.6 ULCERS 131
- 9.6.1 LATERAL FLOW IMMUNO-FOB TEST KITS 132
- 9.6.2 IMMUNO-FOB AGGLUTINATION TEST KITS 132
- 9.6.3 IMMUNO-FOB ELISA TEST KITS 132
- 9.6.4 GUAIAC FOB STOOL TEST 133
- 9.6.5 FLUSHABLE REAGENT PAD OR TISSUE 133
- 9.6.6 OTHERS 133
9.7 HAEMORRHOIDS 133
- 9.7.1 LATERAL FLOW IMMUNO-FOB TEST KITS 134
- 9.7.2 IMMUNO-FOB AGGLUTINATION TEST KITS 134
- 9.7.3 IMMUNO-FOB ELISA TEST KITS 134
- 9.7.4 GUAIAC FOB STOOL TEST 134
- 9.7.5 FLUSHABLE REAGENT PAD OR TISSUE 134
- 9.7.6 OTHERS 134
9.8 COLITIS 135
- 9.8.1 LATERAL FLOW IMMUNO-FOB TEST KITS 136
- 9.8.2 IMMUNO-FOB AGGLUTINATION TEST KITS 136
- 9.8.3 IMMUNO-FOB ELISA TEST KITS 136
- 9.8.4 GUAIAC FOB STOOL TEST 136
- 9.8.5 FLUSHABLE REAGENT PAD OR TISSUE 136
- 9.8.6 OTHERS 136
9.9 ANEMIA 136
- 9.9.1 LATERAL FLOW IMMUNO-FOB TEST KITS 137
- 9.9.2 IMMUNO-FOB AGGLUTINATION TEST KITS 137
- 9.9.3 IMMUNO-FOB ELISA TEST KITS 137
- 9.9.4 GUAIAC FOB STOOL TEST 138
- 9.9.5 FLUSHABLE REAGENT PAD OR TISSUE 138
- 9.9.6 OTHERS 138
9.10 OTHERS 138

10 ASIA PACIFIC FECAL OCCULT BLOOD TESTS MARKET, BY END USER 139

10.1 OVERVIEW 140
10.2 DIAGNOSTIC LABORATORIES 143
10.3 HOSPITALS 143
10.4 SPECIALITY CLINICS 144
10.5 OTHERS 145

11 ASIA PACIFIC FECAL OCCULT BLOOD TESTS MARKET, BY DISTRIBUTION CHANNEL 146

11.1 OVERVIEW 147
11.2 DIRECT TENDER 150
11.3 RETAIL SALE 150
11.4 E-COMMERCE 151
11.5 OTHERS 152

12 ASIA PACIFIC FECAL OCCULT BLOOD TESTS MARKET, BY REGION 153

12.1 ASIA-PACIFIC 154
- 12.1.1 CHINA 167
- 12.1.2 JAPAN 175
- 12.1.3 INDIA 183
- 12.1.4 AUSTRALIA 191
- 12.1.5 SOUTH KOREA 199
- 12.1.6 THAILAND 208
- 12.1.7 SINGAPORE 216
- 12.1.8 INDONESIA 224
- 12.1.9 MALAYSIA 233
- 12.1.10 PHILIPPINES 242
- 12.1.11 REST OF ASIA-PACIFIC 251

13 ASIA PACIFIC FECAL OCCULT BLOOD TESTS MARKET: COMPANY LANDSCAPE 252

13.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC 252

14 SWOT ANALYSIS 253

15 COMPANY PROFILE 254

15.1 QUIDEL CORPORATION 254
- 15.1.1 COMPANY SNAPSHOT 254
- 15.1.2 REVENUE ANALYSIS 254
- 15.1.3 COMPANY SHARE ANALYSIS 255
- 15.1.4 PRODUCT PORTFOLIO 255
- 15.1.5 RECENT DEVELOPMENT 255
15.2 WONDFO. 256
- 15.2.1 COMPANY SNAPSHOT 256
- 15.2.2 COMPANY SHARE ANALYSIS 256
- 15.2.3 PRODUCT PORTFOLIO 257
- 15.2.4 RECENT DEVELOPMENT 257
15.3 SIEMENS HEALTHCARE GMBH 258
- 15.3.1 COMPANY SNAPSHOT 258
- 15.3.2 REVENUE ANALYSIS 258
- 15.3.3 COMPANY SHARE ANALYSIS 259
- 15.3.4 RODUCT PORTFOLIO 259
- 15.3.5 RECENT DEVELOPMENT 259
15.4 EIKEN CHEMICAL CO., LTD. 260
- 15.4.1 COMPANY SNAPSHOT 260
- 15.4.2 REVENUE ANALYSIS 260
- 15.4.3 COMPANY SHARE ANALYSIS 261
- 15.4.4 PRODUCT PORTFOLIO 261
- 15.4.5 RECENT DEVELOPMENT 261
15.5 BIOHIT OYJ 262
- 15.5.1 COMPANY SNAPSHOT 262
- 15.5.2 REVENUE ANALYSIS 262
- 15.5.3 COMPANY SHARE ANALYSIS 263
- 15.5.4 PRODUCT PORTFOLIO 263
- 15.5.5 RECENT DEVELOPMENT 263
15.6 ACCUBIOTECH CO LTD 264
- 15.6.1 COMPANY SNAPSHOT 264
- 15.6.2 PRODUCT PORTFOLIO 264
- 15.6.3 RECENT DEVELOPMENT 264
15.7 ACCUQUIK TEST KITS 265
- 15.7.1 COMPANY SNAPSHOT 265
- 15.7.2 PRODUCT PORTFOLIO 265
- 15.7.3 RECENT DEVELOPMENT 265
15.8 AIDIAN 266
- 15.8.1 COMPANY PROFILE 266
- 15.8.2 PRODUCT PORTFOLIO 266
- 15.8.3 RECENT DEVELOPMENT 266
15.9 ALFA SCIENTIFIC DESIGNS, INC. 267
- 15.9.1 COMPANY SNAPSHOT 267
- 15.9.2 PRODUCT PORTFOLIO 267
- 15.9.3 RECENT DEVELOPMENT 267
15.10 APACOR LIMITED 268
- 15.10.1 COMPANY SNAPSHOT 268
- 15.10.2 PRODUCT PORTFOLIO 268
- 15.10.3 RECENT DEVELOPMENT 268
15.11 BIOPANDA REAGENTS LTD 269
- 15.11.1 COMPANY SNAPSHOT 269
- 15.11.2 PRODUCT PORTFOLIO 269
- 15.11.3 RECENT DEVELOPMENT 269
15.12 BODITECH MED INC. 270
- 15.12.1 COMPANY SNAPSHOT 270
- 15.12.2 PRODUCT PORTFOLIO 270
- 15.12.3 RECENT DEVELOPMENT 270
15.13 CENOGENICS CORPORATION 271
- 15.13.1 COMPANY SNAPSHOT 271
- 15.13.2 PRODUCT PORTFOLIO 271
- 15.13.3 RECENT DEVELOPMENT 271
15.14 CERTEST BIOTEC. 272
- 15.14.1 COMPANY SNAPSHOT 272
- 15.14.2 PRODUCT PORTFOLIO 272
- 15.14.3 RECENT DEVELOPMENT 272
15.15 CTK BIOTECH, INC. 273
- 15.15.1 COMPANY SNAPSHOT 273
- 15.15.2 PRODUCT PORTFOLIO 273
- 15.15.3 RECENT DEVELOPMENT 273
15.16 EDP BIOTECH 274
- 15.16.1 COMPANY SNAPSHOT 274
- 15.16.2 PRODUCT PORTFOLIO 274
- 15.16.3 1.16.3 RECENT DEVELOPMENT 274
15.17 EPITOPE DIAGNOSTICS, INC. 275
- 15.17.1 COMPANY SNAPSHOT 275
- 15.17.2 PRODUCT PORTFOLIO 275
- 15.17.3 RECENT DEVELOPMENT 275
15.18 EUROLYSER DIAGNOSTICA GMBH 276
- 15.18.1 COMPANY SNAPSHOT 276
- 15.18.2 PRODUCT PORTFOLIO 276
- 15.18.3 RECENT DEVELOPMENT 276
15.19 FIRSTEP 277
- 15.19.1 COMPANY SNAPSHOT 277
- 15.19.2 PRODUCT PORTFOLIO 277
- 15.19.3 RECENT DEVELOPMENT 277
15.20 HANGZHOU CLONGENE BIOTECH CO., LTD 278
- 15.20.1 COMPANY SNAPSHOT 278
- 15.20.2 PRODUCT PORTFOLIO 278
- 15.20.3 RECENT DEVELOPMENT 278

15.21 HUMASIS.COM 279
- 15.21.1 COMPANY SNAPSHOT 279
- 15.21.2 PRODUCT PORTFOLIO 279
- 15.21.3 RECENT DEVELOPMENT 279
15.22 JANT PHARMACAL CORPORATION 280
- 15.22.1 COMPANY SNAPSHOT 280
- 15.22.2 PRODUCT PORTFOLIO 280
- 15.22.3 RECENT DEVELOPMENT 280
15.23 PRIMA LAB SA 281
- 15.23.1 COMPANY SNAPSHOT 281
- 15.23.2 PRODUCT PORTFOLIO 281
- 15.23.3 RECENT DEVELOPMENT 281
15.24 ULTI MED PRODUCTS (DEUTSCHLAND) GMBH 282
- 15.24.1 COMPANY SNAPSHOT 282
- 15.24.2 PRODUCT PORTFOLIO 282
- 15.24.3 RECENT DEVELOPMENT 282

16 QUESTIONNAIRE 283

17 RELATED REPORTS 286

LIST OF TABLES

TABLE 1 ASIA PACIFIC FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 72
TABLE 2 ASIA PACIFIC LATERAL FLOW IMMUNO-FOB TEST KITS IN FECAL OCCULT MARKET, BY REGION, 2021-2030 (USD MILLION) 73
TABLE 3 ASIA PACIFIC IMMUNO-FOB AGGLUTINATION TEST KITS IN FECAL OCCULT MARKET, BY REGION, 2021-2030 (USD MILLION) 74
TABLE 4 ASIA PACIFIC IMMUNO-FOB ELISA TEST KITS IN FECAL OCCULT MARKET, BY REGION, 2021-2030 (USD MILLION) 74
TABLE 5 ASIA PACIFIC GUAIAC FOB STOOL TEST IN FECAL OCCULT MARKET, BY REGION, 2021-2030 (USD MILLION) 75
TABLE 6 ASIA PACIFIC GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 75
TABLE 7 ASIA PACIFIC KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 76
TABLE 8 ASIA PACIFIC GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 76
TABLE 9 ASIA PACIFIC ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 77
TABLE 10 ASIA PACIFIC SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 77
TABLE 11 ASIA PACIFIC SENSITIVITY IS 75NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 78
TABLE 12 ASIA PACIFIC REAGENTS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 79
TABLE 13 ASIA PACIFIC FLUSHABLE REAGENT PAD OR TISSUE IN FECAL OCCULT MARKET, BY REGION, 2021-2030 (USD MILLION) 80
TABLE 14 ASIA PACIFIC OTHERS IN FECAL OCCULT MARKET, BY REGION, 2021-2030 (USD MILLION) 80
TABLE 15 ASIA PACIFIC FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 84
TABLE 16 ASIA PACIFIC COLORECTAL CANCER SCREENING IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 85
TABLE 17 ASIA PACIFIC COLORECTAL CANCER SCREENING IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 85
TABLE 18 ASIA PACIFIC CONCERN FOR GASTROINTESTINAL BLEEDING IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 87
TABLE 19 ASIA PACIFIC CONCERN FOR GASTROINTESTINAL BLEEDING IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 87
TABLE 20 ASIA PACIFIC POYLPS IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 88
TABLE 21 ASIA PACIFIC POLYPS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 89
TABLE 22 ASIA PACIFIC DIVERTICULOSIS IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 90
TABLE 23 ASIA PACIFIC DIVERTICULOSIS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 90
TABLE 24 ASIA PACIFIC ULCERS IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 92
TABLE 25 ASIA PACIFIC ULCERS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 92
TABLE 26 ASIA PACIFIC HAEMORRHOIDS IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 93
TABLE 27 ASIA PACIFIC HEMORRHOIDS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 94
TABLE 28 ASIA PACIFIC COLITIS IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 95
TABLE 29 ASIA PACIFIC COLITIS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 95
TABLE 30 ASIA PACIFIC ANEMIA IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 97
TABLE 31 ASIA PACIFIC ANEMIA IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 97
TABLE 32 ASIA PACIFIC OTHERS IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 98
TABLE 33 ASIA PACIFIC FECAL OCCULT BLOOD TESTS MARKET, BY END USER, 2021-2030 (USD MILLION) 102
TABLE 34 ASIA PACIFIC DIAGNOSTIC LABORATORIES IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 103
TABLE 35 ASIA PACIFIC HOSPITALS IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 104
TABLE 36 ASIA PACIFIC SPECIALITY CLINICS IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 104
TABLE 37 ASIA PACIFIC OTHERS IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 105
TABLE 38 ASIA PACIFIC FECAL OCCULT BLOOD TESTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 109
TABLE 39 ASIA PACIFIC DIRECT TENDER IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 110
TABLE 40 ASIA PACIFIC RETAIL SALE IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 111
TABLE 41 ASIA PACIFIC RETAIL SALE IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 111
TABLE 42 ASIA PACIFIC OTHERS IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 112
TABLE 43 ASIA-PACIFIC FECAL OCCULT BLOOD TESTS MARKET, BY COUNTRY, 2021-2030 (USD MILLION) 118
TABLE 44 ASIA-PACIFIC FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 118
TABLE 45 ASIA-PACIFIC FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 118
TABLE 46 ASIA-PACIFIC FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 119
TABLE 47 ASIA-PACIFIC GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 119
TABLE 48 ASIA-PACIFIC GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 119
TABLE 49 ASIA-PACIFIC GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 119
TABLE 50 ASIA-PACIFIC KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 119
TABLE 51 ASIA-PACIFIC KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 120
TABLE 52 ASIA-PACIFIC KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 120
TABLE 53 ASIA-PACIFIC GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 120
TABLE 54 ASIA-PACIFIC GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 120
TABLE 55 ASIA-PACIFIC GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 120
TABLE 56 ASIA-PACIFIC ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 120
TABLE 57 ASIA-PACIFIC ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 121
TABLE 58 ASIA-PACIFIC ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 121
TABLE 59 ASIA-PACIFIC SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 121
TABLE 60 ASIA-PACIFIC SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 121
TABLE 61 ASIA-PACIFIC SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 121
TABLE 62 ASIA-PACIFIC SENSITIVITY IS 75NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 121
TABLE 63 ASIA-PACIFIC SENSITIVITY IS 75NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 122
TABLE 64 ASIA-PACIFIC SENSITIVITY IS 75NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 122
TABLE 65 ASIA-PACIFIC REAGENTS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 122
TABLE 66 ASIA-PACIFIC REAGENTS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 122
TABLE 67 ASIA-PACIFIC REAGENTS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 122
TABLE 68 ASIA-PACIFIC FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 123
TABLE 69 ASIA-PACIFIC COLORECTAL CANCER SCREENING IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 123
TABLE 70 ASIA-PACIFIC CONCERN FOR GASTROINTESTINAL BLEEDING IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 123
TABLE 71 ASIA-PACIFIC POLYPS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 124
TABLE 72 ASIA-PACIFIC DIVERTICULOSIS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 124
TABLE 73 ASIA-PACIFIC ULCERS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 124
TABLE 74 ASIA-PACIFIC HAEMORRHOIDS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 125
TABLE 75 ASIA-PACIFIC COLITIS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 125
TABLE 76 ASIA-PACIFIC ANEMIA IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 125
TABLE 77 ASIA-PACIFIC FECAL OCCULT BLOOD TESTS MARKET, BY END USER, 2021-2030 (USD MILLION) 126
TABLE 78 ASIA-PACIFIC FECAL OCCULT BLOOD TESTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 126
TABLE 79 CHINA FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 127
TABLE 80 CHINA FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 127
TABLE 81 CHINA FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 127
TABLE 82 CHINA GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 127
TABLE 83 CHINA GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 128
TABLE 84 CHINA GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 128
TABLE 85 CHINA KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 128
TABLE 86 CHINA KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 128
TABLE 87 CHINA KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 128
TABLE 88 CHINA GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 128
TABLE 89 CHINA GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 129
TABLE 90 CHINA GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 129
TABLE 91 CHINA ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 129
TABLE 92 CHINA ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 129
TABLE 93 CHINA ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 129
TABLE 94 CHINA SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 129
TABLE 95 CHINA SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 130
TABLE 96 CHINA SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 130
TABLE 97 CHINA SENSITIVITY IS 75NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 130
TABLE 98 CHINA SENSITIVITY IS 75NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 130
TABLE 99 CHINA SENSITIVITY IS 75NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 130
TABLE 100 CHINA REAGENTS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 130
TABLE 101 CHINA REAGENTS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 131
TABLE 102 CHINA REAGENTS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 131
TABLE 103 CHINA FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 131
TABLE 104 CHINA COLORECTAL CANCER SCREENING IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 131
TABLE 105 CHINA CONCERN FOR GASTROINTESTINAL BLEEDING IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 132
TABLE 106 CHINA POLYPS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 132
TABLE 107 CHINA DIVERTICULOSIS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 132
TABLE 108 CHINA ULCERS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 133
TABLE 109 CHINA HAEMORRHOIDS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 133
TABLE 110 CHINA COLITIS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 133
TABLE 111 CHINA ANEMIA IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 134
TABLE 112 CHINA FECAL OCCULT BLOOD TESTS MARKET, BY END USER, 2021-2030 (USD MILLION) 134
TABLE 113 CHINA FECAL OCCULT BLOOD TESTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 134
TABLE 114 JAPAN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 135
TABLE 115 JAPAN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 135
TABLE 116 JAPAN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 135
TABLE 117 JAPAN GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 135
TABLE 118 JAPAN GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 136
TABLE 119 JAPAN GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 136
TABLE 120 JAPAN KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 136
TABLE 121 JAPAN KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 136
TABLE 122 JAPAN KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 136
TABLE 123 JAPAN GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 136
TABLE 124 JAPAN GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 137
TABLE 125 JAPAN GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 137
TABLE 126 JAPAN ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 137
TABLE 127 JAPAN ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 137
TABLE 128 JAPAN ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 137
TABLE 129 JAPAN SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 137
TABLE 130 JAPAN SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 138
TABLE 131 JAPAN SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 138
TABLE 132 JAPAN SENSITIVITY IS 75NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 138
TABLE 133 JAPAN SENSITIVITY IS 75NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 138
TABLE 134 JAPAN SENSITIVITY IS 75NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 138
TABLE 135 JAPAN REAGENTS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 138
TABLE 136 JAPAN REAGENTS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 139
TABLE 137 JAPAN REAGENTS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 139
TABLE 138 JAPAN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 139
TABLE 139 JAPAN COLORECTAL CANCER SCREENING IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 139
TABLE 140 JAPAN CONCERN FOR GASTROINTESTINAL BLEEDING IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 140
TABLE 141 JAPAN POLYPS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 140
TABLE 142 JAPAN DIVERTICULOSIS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 140
TABLE 143 JAPAN ULCERS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 141
TABLE 144 JAPAN HAEMORRHOIDS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 141
TABLE 145 JAPAN COLITIS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 141
TABLE 146 JAPAN ANEMIA IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 142
TABLE 147 JAPAN FECAL OCCULT BLOOD TESTS MARKET, BY END USER, 2021-2030 (USD MILLION) 142
TABLE 148 JAPAN FECAL OCCULT BLOOD TESTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 142
TABLE 149 INDIA FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 143
TABLE 150 INDIA FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 143
TABLE 151 INDIA FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 143
TABLE 152 INDIA GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 143
TABLE 153 INDIA GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 144
TABLE 154 INDIA GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 144
TABLE 155 INDIA KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 144
TABLE 156 INDIA KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 144
TABLE 157 INDIA KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 144
TABLE 158 INDIA GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 144
TABLE 159 INDIA GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 145
TABLE 160 INDIA GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 145
TABLE 161 INDIA ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 145
TABLE 162 INDIA ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 145
TABLE 163 INDIA ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 145
TABLE 164 INDIA SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 145
TABLE 165 INDIA SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 146
TABLE 166 INDIA SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 146
TABLE 167 INDIA SENSITIVITY IS 75NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 146
TABLE 168 INDIA SENSITIVITY IS 75NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 146
TABLE 169 INDIA SENSITIVITY IS 75NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 146
TABLE 170 INDIA REAGENTS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 146
TABLE 171 INDIA REAGENTS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 147
TABLE 172 INDIA REAGENTS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 147
TABLE 173 INDIA FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 147
TABLE 174 INDIA COLORECTAL CANCER SCREENING IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 147
TABLE 175 INDIA CONCERN FOR GASTROINTESTINAL BLEEDING IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 148
TABLE 176 INDIA POLYPS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 148
TABLE 177 INDIA DIVERTICULOSIS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 148
TABLE 178 INDIA ULCERS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 149
TABLE 179 INDIA HAEMORRHOIDS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 149
TABLE 180 INDIA COLITIS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 149
TABLE 181 INDIA ANEMIA IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 150
TABLE 182 INDIA FECAL OCCULT BLOOD TESTS MARKET, BY END USER, 2021-2030 (USD MILLION) 150
TABLE 183 INDIA FECAL OCCULT BLOOD TESTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 150
TABLE 184 AUSTRALIA FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 151
TABLE 185 AUSTRALIA FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 151
TABLE 186 AUSTRALIA FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 151
TABLE 187 AUSTRALIA GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 151
TABLE 188 AUSTRALIA GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 152

LIST OF FIGURES

FIGURE 1 ASIA PACIFIC FECAL OCCULT BLOOD TESTSMARKET: SEGMENTATION 40
FIGURE 2 ASIA PACIFIC FECAL OCCULT BLOOD TESTS MARKET: DATA TRIANGULATION 43
FIGURE 3 ASIA PACIFIC FECAL OCCULT BLOOD TESTS MARKET: DROC ANALYSIS 44
FIGURE 4 ASIA PACIFIC FECAL OCCULT BLOOD TESTS MARKET: ASIA PACIFIC VS REGIONAL MARKET ANALYSIS 45
FIGURE 5 ASIA PACIFIC FECAL OCCULT BLOOD TESTS MARKET: COMPANY RESEARCH ANALYSIS 45
FIGURE 6 ASIA PACIFIC FECAL OCCULT BLOOD TESTS MARKET: INTERVIEW DEMOGRAPHICS 46
FIGURE 7 ASIA PACIFIC FECAL OCCULT BLOOD TESTS MARKET: MARKET APPLICATION COVERAGE GRID 48
FIGURE 8 ASIA PACIFIC FECAL OCCULT BLOOD TESTSMARKET: DBMR MARKET POSITION GRID 49
FIGURE 9 ASIA PACIFIC FECAL OCCULT BLOOD TESTS MARKET: VENDOR SHARE ANALYSIS 50
FIGURE 10 ASIA PACIFIC FECAL OCCULT BLOOD TESTS MARKET: SEGMENTATION 53
FIGURE 11 RISING CASES OF COLORECTAL CANCER ASIA PACIFICLY AND EASY AVAILABILITY OF FECAL OCCULT IMMUNOLOGICAL TEST DEVICES IN ONLINE STORES ARE EXPECTED TO DRIVE THE GROWTH OF THE ASIA PACIFIC FECAL OCCULT BLOOD TESTS MARKET FROM 2023 TO 2030 54
FIGURE 12 THE LATERAL FLOW IMMUNO-FOB, TEST KITS SEGMENT, IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA PACIFIC FECAL OCCULT BLOOD TESTS MARKET IN 2023 & 2030 54
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE ASIA PACIFIC FECAL OCCULT BLOOD TESTS MARKET 62
FIGURE 14 ASIA PACIFIC FECAL OCCULT BLOOD TESTS MARKET: BY TEST TYPE, 2022 69
FIGURE 15 ASIA PACIFIC FECAL OCCULT BLOOD TESTS MARKET: BY TEST TYPE, 2023-2030 (USD MILLION) 70
FIGURE 16 ASIA PACIFIC FECAL OCCULT BLOOD TESTS MARKET: BY TEST TYPE, CAGR (2023-2030) 70
FIGURE 17 ASIA PACIFIC FECAL OCCULT BLOOD TESTS MARKET: BY TEST TYPE, LIFELINE CURVE 71
FIGURE 18 ASIA PACIFIC FECAL OCCULT BLOOD TESTS MARKET: BY APPLICATION, 2022 81
FIGURE 19 ASIA PACIFIC FECAL OCCULT BLOOD TESTS MARKET: BY APPLICATION, 2023-2030 (USD MILLION) 82
FIGURE 20 ASIA PACIFIC FECAL OCCULT BLOOD TESTS MARKET: BY APPLICATION, CAGR (2023-2030) 82
FIGURE 21 ASIA PACIFIC FECAL OCCULT BLOOD TESTS MARKET: BY APPLICATION, LIFELINE CURVE 83
FIGURE 22 ASIA PACIFIC FECAL OCCULT BLOOD TESTS MARKET: BY END USER, 2022 99
FIGURE 23 ASIA PACIFIC FECAL OCCULT BLOOD TESTS MARKET: BY END USER, 2023-2030 (USD MILLION) 100
FIGURE 24 ASIA PACIFIC FECAL OCCULT BLOOD TESTS MARKET: BY END USER, CAGR (2023-2030) 100
FIGURE 25 ASIA PACIFIC FECAL OCCULT BLOOD TESTS MARKET : BY END USER, LIFELINE CURVE 101
FIGURE 26 ASIA PACIFIC FECAL OCCULT BLOOD TESTS MARKET : BY DISTRIBUTION CHANNEL, 2022 106
FIGURE 27 ASIA PACIFIC FECAL OCCULT BLOOD TESTS MARKET : BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 107
FIGURE 28 ASIA PACIFIC FECAL OCCULT BLOOD TESTS MARKET : BY DISTRIBUTION CHANNEL, CAGR (2023-2030) 107
FIGURE 29 ASIA PACIFIC FECAL OCCULT BLOOD TESTS MARKET : BY DISTRIBUTION CHANNEL, LIFELINE CURVE 108
FIGURE 30 ASIA-PACIFIC FECAL OCCULT BLOOD TESTS MARKET: SNAPSHOT (2022) 114
FIGURE 31 ASIA-PACIFIC FECAL OCCULT BLOOD TESTS MARKET: BY COUNTRY (2022) 115
FIGURE 32 ASIA-PACIFIC FECAL OCCULT BLOOD TESTS MARKET: BY COUNTRY (2023 & 2030) 115
FIGURE 33 ASIA-PACIFIC FECAL OCCULT BLOOD TESTS MARKET: BY COUNTRY (2022 & 2030) 116
FIGURE 34 ASIA-PACIFIC FECAL OCCULT BLOOD TESTS MARKET: BY TEST TYPE (2023-2030) 116
FIGURE 35 ASIA PACIFIC FECAL OCCULT BLOOD TESTS MARKET: COMPANY SHARE 2022 (%) 211